Live feed16:05:06·19hINSIDERFilingChief Research Officer Rote William E. sold $355,719 worth of shares (9,100 units at $39.09) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 113,987 units (SEC Form 4)TVTX· Travere Therapeutics Inc.Health CareOriginal source